ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has announced the composition of its Board of Directors, including Executive, Non-executive, and Independent Non-executive members. The company also disclosed the structure of its three Board committees—Audit, Remuneration, and Nomination—detailing the roles of each director with specific committee chairmanships and memberships.
For further insights into HK:1541 stock, check out TipRanks’ Stock Analysis page.